Citations 1
A phase I trial of veliparib, an inhibitor of poly(ADP-ribose) polymerase (PARP), and topotecan (TPT) in patients with solid tumors.
Hendrickson, Andrea E. Wahner , Menefee, Michael E., Hartmann, Lynn C., Long, Harry J., Northfelt, Donald W. , Boakye-Agyeman, Fleix, Flatten, Karen S., Lensing, Janet L., Erlichman, Charles , Reid, Joel M. , Poirier, Guy G. , Kaufmann, Scott H. , Haluska, Paul
Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: TPS2618-TPS2618
